added 2007 Wed May 9 18:12:41 by KelLuv
BOSTON (Reuters) - Massachusetts' governor proposed on Tuesday to spend $1 billion on biotechnology over 10 years, aiming to fill a federal funding shortfall caused by the Bush administration's opposition to embryonic stem-cell research.
BOSTON (Reuters) - Massachusetts' governor proposed on Tuesday to spend $1 billion on biotechnology over 10 years, aiming to fill a federal funding shortfall caused by the Bush administration's opposition to embryonic stem-cell research.
added 2007 Wed Feb 21 16:46:56 by bhartzer
Access Pharmaceuticals and Somanta Pharmaceuticals have signed a letter of intent for Access to acquire Somanta. Somanta is an Irvine, California based biotechnology company with four novel anti-cancer compounds in development, one of which is currently in Phase 2 clinical trials.
Access Pharmaceuticals and Somanta Pharmaceuticals have signed a letter of intent for Access to acquire Somanta. Somanta is an Irvine, California based biotechnology company with four novel anti-cancer compounds in development, one of which is currently in Phase 2 clinical trials.
